Mizuho analysts increased their price target for Intuitive Surgical (NASDAQ:ISRG) to $440 from $390 while maintaining their Neutral rating, ahead of the company’s Q2 earnings, scheduled to be released on Thursday.

The adjustment follows proprietary channel checks for Q2/24, which included interactions with 12 public and private companies, four key opinion leader events, and two in-depth surveys. The analysts cited expectations for the da Vinci 5 system and minimal competitive pressures as reasons for the price target increase.